What Patients are Reading About Prenatal Cell‐Free DNA: An Analysis of Leading Publicly Available AI‐Chatbots
Prenatal Diagnosis · 14.11.2026
DOI: 10.1002/pd.70291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, online erschienen am 14.11.2026. Verfasst von Miller S Finkelstein und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Subspeciality OB/GYN, Women and Children's Institute, Cleveland Clinic, Cleveland, Ohio, USA. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHGRI NIH HHS, National Human Genome Research Institute.
Abstract (Originalsprache)
Objective
To characterize the quality, consistency, and framing of information about prenatal cell‐free DNA (cfDNA) screening generated by publicly available chatbots, including variation across simulated user age profiles.
Methods
We conducted a qualitative content analysis of outputs from three publicly available chatbots. To reduce carryover effects and personalization, prompts were entered using a VPN, private browsing, and cleared browser cookies. Outputs were generated using distinct simulated user age profiles. Analysis examined informational completeness, framing of benefits and limitations, terminology, source transparency, and age‐related differences in responses.
Results
Chatbot outputs varied substantially across platforms and user profiles, with misinformation, omissions, and incomplete information identified. Common themes included inconsistent explanations of the purpose and scope of cfDNA screening, frequent omission of test limitations and downstream implications, and variable readability scores (at a 9th–14th grade level) and terminology that sometimes conflate screening with diagnostic testing. Citations to high‐quality sources were limited or absent. Age‐based profile variation was associated with differences in tone, complexity, and emphasis, suggesting implicit tailoring of information presentation.
Conclusion
Publicly available chatbots may provide inaccurate or inconsistent information about cfDNA screening. As these tools are increasingly used outside clinical settings, improving accuracy, transparency, discussion of limitations, and source citation is essential to support reliable patient‐facing health information.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Subspeciality OB/GYN, Women and Children's Institute, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Biomedical Informatics & Center for Biomedical Ethics and Society, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Center for Personalized Genetic Healthcare, Cleveland Clinic, Cleveland, Ohio, USA.
- Center for Bioethics, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID-Profile: Miller S Finkelstein, Susannah L Rose, Lenicia Jenkins, Christina Collart, Ruth M Farrell
Förderung
- NHGRI NIH HHS
- National Human Genome Research Institute
Zitieren
APA
Finkelstein, M. S., Rose, S. L., Jenkins, L., Collart, C., & Farrell, R. M. (2026). What Patients are Reading About Prenatal Cell‐Free DNA: An Analysis of Leading Publicly Available AI‐Chatbots. Prenatal Diagnosis. https://doi.org/10.1002/pd.70291
Vancouver
Finkelstein MS, Rose SL, Jenkins L, Collart C, Farrell RM. What Patients are Reading About Prenatal Cell‐Free DNA: An Analysis of Leading Publicly Available AI‐Chatbots. Prenatal Diagnosis. 2026. doi:10.1002/pd.70291
BibTeX
@article{Finkelstein2026,
author = {Finkelstein, Miller S and Rose, Susannah L and Jenkins, Lenicia and Collart, Christina and Farrell, Ruth M},
title = {What Patients are Reading About Prenatal Cell‐Free DNA: An Analysis of Leading Publicly Available AI‐Chatbots},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70291}
}
EUVIMED